Exploiting translation inhibition: antitumor efficacy of SVC112 in preclinical models of colorectal cancer

被引：0
|
作者：
Robertson, Kelli M. [1 ]
Gustafson, Annika L. [1 ]
Tentler, John J. [1 ]
Bagby, Stacey M. [1 ]
Anna, Capasso [1 ]
Klauck, Peter J. [1 ]
Pitts, Todd M. [1 ]
Kim, Jihye [1 ]
Tan, Aik Choon [1 ]
Su, Tin Tin [2 ]
Eckhardt, S. Gail [1 ]
机构：
[1] Univ Colorado, Sch Med, Denver, CO USA
[2] Univ Colorado, Denver, CO 80202 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B051
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pancreatic cancer: ROCK inhibition sensitizes preclinical models
    Sidaway P.
    Nature Reviews Clinical Oncology, 2017, 14 (6) : 328 - 328
  • [32] Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia
    Alferez, Dents G.
    Goodlad, Robert A.
    Odedra, Rajesh
    Sini, Patrizia
    Crafter, Claire
    Ryan, Anderson J.
    Wedge, Stephen R.
    Wright, Nicholas A.
    Anderson, Elizabeth
    Wilkinson, Robert W.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (04) : 1475 - 1485
  • [33] "Theranostics" - Radioimmunodetection and Radioimmunotherapy for Metastatic Colorectal Cancer in Preclinical Cancer Models
    Cuda, T.
    Thomas, P.
    Rose, S.
    Puttick, S.
    Hooper, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S686 - S687
  • [34] Antitumor activities of targeted therapeutic agents in preclinical models of gastric cancer
    Fan, Conglin
    Pascual, Bernadette
    Wu, Ying
    Whalen, Pamela
    Wang, Yuli
    Pocalyko, David
    Li, Gang
    CANCER RESEARCH, 2011, 71
  • [35] Combination therapy elicited antitumor immune responses in preclinical models of cancer
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1036 - 1036
  • [36] Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer
    Xie, Liguo
    Cheng, Lifangyu
    Wei, Yunlin
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 243
  • [37] Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models
    Settanni, Carlo R.
    Quaranta, Gianluca
    Bibbo, Stefano
    Gasbarrini, Antonio
    Cammarota, Giovanni
    Ianiro, Gianluca
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (01) : 48 - 69
  • [38] MICROSCOPIC CHARACTERIZATION OF IN VITRO AND IN VIVO PRECLINICAL MODELS OF COLORECTAL CANCER
    Zonfrillo, M.
    Moroni, N.
    Mercuri, L.
    Andreola, F.
    Psaila, R.
    Guarino, E.
    Rasi, G.
    Serafino, A.
    Pierimarchi, P.
    CYTOMETRY PART A, 2010, 77A (02) : 202 - 202
  • [39] TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models
    Young, Kristina H.
    Newell, Pippa
    Cottam, Benjamin
    Friedman, David
    Savage, Talicia
    Baird, Jason R.
    Akporiaye, Emmanuel
    Gough, Michael J.
    Crittenden, Marka
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (10) : 1011 - 1022
  • [40] NEDD8 pathway inhibition is effective in preclinical models of poorly differentiated, clinically aggressive colorectal cancer
    Picco, Gabriele
    Sassi, Francesco
    Isella, Claudio
    Di Nicolantonio, Federica
    Sapino, Anna
    Bardelli, Alberto
    Trusolino, Livio
    Berton, Andrea
    Medico, Enzo
    CANCER RESEARCH, 2016, 76
12345